Mettler-Toledo International, Inc. (NYSE:MTD) CFO Shawn Vadala sold 300 shares of the company’s stock in a transaction that occurred on Monday, November 20th. The shares were sold at an average price of $630.00, for a total transaction of $189,000.00. Following the completion of the sale, the chief financial officer now directly owns 5,599 shares of the company’s stock, valued at approximately $3,527,370. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Shawn Vadala also recently made the following trade(s):

  • On Monday, November 13th, Shawn Vadala sold 226 shares of Mettler-Toledo International stock. The stock was sold at an average price of $629.36, for a total transaction of $142,235.36.

Mettler-Toledo International, Inc. (MTD) traded down $4.30 during trading on Wednesday, reaching $627.62. 94,800 shares of the company were exchanged, compared to its average volume of 157,917. The company has a market capitalization of $16,163.96, a P/E ratio of 37.39, a P/E/G ratio of 2.89 and a beta of 1.13. The company has a current ratio of 1.51, a quick ratio of 1.11 and a debt-to-equity ratio of 2.05. Mettler-Toledo International, Inc. has a 1-year low of $407.87 and a 1-year high of $694.48.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, November 2nd. The medical instruments supplier reported $4.36 EPS for the quarter, beating analysts’ consensus estimates of $4.32 by $0.04. The firm had revenue of $698.80 million during the quarter, compared to analysts’ expectations of $685.56 million. Mettler-Toledo International had a net margin of 16.44% and a return on equity of 96.81%. The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter last year, the company posted $3.89 earnings per share. analysts predict that Mettler-Toledo International, Inc. will post 17.52 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Shawn Vadala Sells 300 Shares of Mettler-Toledo International, Inc. (MTD) Stock” was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this news story can be read at https://www.watchlistnews.com/shawn-vadala-sells-300-shares-of-mettler-toledo-international-inc-mtd-stock/1719756.html.

Several equities research analysts have recently issued reports on MTD shares. Goldman Sachs Group, Inc. (The) reissued a “buy” rating and set a $690.00 price objective on shares of Mettler-Toledo International in a research report on Tuesday, September 26th. Zacks Investment Research raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and set a $711.00 price objective for the company in a research report on Thursday, September 21st. BidaskClub raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Monday, August 14th. Bank of America Corporation increased their price objective on shares of Mettler-Toledo International from $640.00 to $710.00 and gave the stock a “buy” rating in a research report on Monday, October 9th. Finally, Morgan Stanley increased their price objective on shares of Mettler-Toledo International from $535.00 to $545.00 and gave the stock an “equal weight” rating in a research report on Friday, November 3rd. Five research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $621.57.

A number of hedge funds have recently made changes to their positions in the business. First Personal Financial Services lifted its stake in Mettler-Toledo International by 2.8% in the second quarter. First Personal Financial Services now owns 186 shares of the medical instruments supplier’s stock valued at $109,000 after acquiring an additional 5 shares during the last quarter. Contravisory Investment Management Inc. lifted its stake in Mettler-Toledo International by 1.3% in the second quarter. Contravisory Investment Management Inc. now owns 558 shares of the medical instruments supplier’s stock valued at $328,000 after acquiring an additional 7 shares during the last quarter. Advisor Partners LLC lifted its stake in Mettler-Toledo International by 3.5% in the second quarter. Advisor Partners LLC now owns 468 shares of the medical instruments supplier’s stock valued at $275,000 after acquiring an additional 16 shares during the last quarter. Alps Advisors Inc. lifted its stake in Mettler-Toledo International by 1.4% in the second quarter. Alps Advisors Inc. now owns 1,225 shares of the medical instruments supplier’s stock valued at $721,000 after acquiring an additional 17 shares during the last quarter. Finally, Commonwealth Bank of Australia lifted its stake in Mettler-Toledo International by 3.1% in the second quarter. Commonwealth Bank of Australia now owns 562 shares of the medical instruments supplier’s stock valued at $329,000 after acquiring an additional 17 shares during the last quarter. Hedge funds and other institutional investors own 93.38% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications.

Insider Buying and Selling by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.